Results 1 to 10 of about 1,208 (147)

Symptomatic Uncomplicated Diverticular Disease (SUDD): Practical Guidance and Challenges for Clinical Management [PDF]

Clinical and Experimental Gastroenterology, 2023
Giacomo Calini,1– 4 Mohamed A Abd El Aziz,1,5 Lucia Paolini,6 Solafah Abdalla,1,7 Matteo Rottoli,3,4 Giulio Mari,8 David W Larson1 1Division of Colon and Rectal Surgery, Mayo Clinic, Rochester, MN, USA; 2Department of Medical Area, University of Udine ...
Calini G, Abd El Aziz MA, Paolini L, Abdalla S, Rottoli M, Mari G, Larson DW   +6 more
doaj   +8 more sources

Patients with symptomatic uncomplicated diverticular disease have high fecal bile acid concentrations [PDF]

Frontiers in Medicine
Background and AimSymptomatic uncomplicated diverticular disease (SUDD) causes persistent pain and impairs patient quality of life; however, its pathogenesis remains unknown.
Tsumugi Jono, Tsumugi Jono, Yuki Kasai, Takaomi Kessoku, Takaomi Kessoku, Takaomi Kessoku, Kosuke Tanaka, Kosuke Tanaka, Michihiro Iwaki, Takashi Kobayashi, Kota Takahashi, Kosuke Seita, Takayuki Kato, Eiji Sakai, Takeo Kurihashi, Machiko Nakatogawa, Shunsuke Oyamada, Seiji Futagami, Kok-Ann Gwee, Atsushi Nakajima, Antonio Tursi   +20 more
doaj   +6 more sources

Development and validation of a diverticular clinical score for symptomatic uncomplicated diverticular disease after acute diverticulitis in a prospective patient cohort [PDF]

Therapeutic Advances in Gastroenterology, 2020
Background: Following an attack of acute diverticulitis (AD), many patients continue to suffer from a complex of symptoms, titled ‘symptomatic uncomplicated diverticular disease (SUDD)’.
Adi Lahat, Herma H Fidder, Shomron Ben-Horin   +2 more
doaj   +3 more sources

Micro-encapsulated and colonic-release sodium butyrate modulates gut microbiota and improves abdominal pain in patients with symptomatic uncomplicated diverticular disease [PDF]

Frontiers in Medicine
The role of gut microbiota (GM) in the pathogenesis of Symptomatic Uncomplicated Diverticular Disease (SUDD) remains controversial. Here, we assessed the efficacy of a butyrate formulation in modulating GM and abdominal pain in patients with SUDD.
Antonio Tursi, Antonio Tursi, Giorgia Procaccianti, Rudi De Bastiani, Silvia Turroni, Federica D’Amico, Leonardo Allegretta, Natale Antonino, Elisabetta Baldi, Carlo Casamassima, Giovanni Casella, Mario Ciuffi, Marco De Bastiani, Lorenzo Lazzarotto, Claudio Licci, Maurizio Mancuso, Antonio Penna, Giuseppe Pranzo, Guido Sanna, Cesare Tosetti, Maria Zamparella, Marcello Picchio   +21 more
doaj   +4 more sources

Evaluation of the Effect of a Cranberry Formulation in Reducing the Inflammatory State and Improving the Management of Symptoms in Patients with Symptomatic Uncomplicated Diverticular Disease: A Prospective, Open-Label, Single-Arm, Multi-Center, Pilot Study [PDF]

Pharmaceutics
Background/Objectives: Low-grade inflammation and microbial imbalance have been thought to play a role in the pathogenesis of Symptomatic Uncomplicated Diverticular Disease (SUDD).
Antonio Tursi, Stefano Rodinò, Ladislava Sebkova, Federica Furfaro, Silvio Danese   +4 more
doaj   +4 more sources

Unmet needs in treatment of symptomatic uncomplicated diverticular disease and prevention of recurrent acute diverticulitis: a scoping review [PDF]

Therapeutic Advances in Gastroenterology
Background: Diverticular disease (DD) represents a common gastrointestinal condition that poses a heavy burden on healthcare systems worldwide. A high degree of uncertainty surrounds the therapeutic approaches for the control of symptoms in patients with
Marilia Carabotti, Rosario Cuomo, Giovanni Marasco, Giovanni Barbara, Franco Radaelli, Bruno Annibale   +5 more
doaj   +3 more sources

Gut Microbiota and Related Electronic Multisensorial System Changes in Subjects With Symptomatic Uncomplicated Diverticular Disease Undergoing Rifaximin Therapy [PDF]

Frontiers in Medicine, 2021
Background: Intestinal dysbiosis might play a pathogenetic role in subjects with symptomatic uncomplicated diverticular disease (SUDD), but the effect of rifaximin therapy has been scantly explored with regard to gut microbiota variations in patients ...
Antonio De Vincentis, Marco Santonico, Federica Del Chierico, Annamaria Altomare, Benedetta Marigliano, Alice Laudisio, Sofia Reddel, Simone Grasso, Alessandro Zompanti, Giorgio Pennazza, Lorenza Putignani, Lorenza Putignani, Michele Pier Luca Guarino, Michele Cicala, Raffaele Antonelli Incalzi   +14 more
doaj   +2 more sources

Eubiotic effect of rifaximin is associated with decreasing abdominal pain in symptomatic uncomplicated diverticular disease: results from an observational cohort study [PDF]

BMC Gastroenterology, 2023
Background Rifaximin effectively treats symptomatic uncomplicated diverticular disease (SUDD) and has shown eubiotic potential (i.e., an increase in resident microbial elements with potential beneficial effects) in other diseases. This study investigated
Vladimir Ivashkin, Oleg Shifrin, Roman Maslennikov, Elena Poluektova, Alexander Korolev, Anna Kudryavtseva, George Krasnov, Nona Benuni, Giovanni Barbara   +8 more
doaj   +2 more sources

Symptomatic uncomplicated diverticular disease management: an innovative food-grade formulation of Curcuma longa and Boswellia serrata extracts [PDF]

Drugs in Context, 2020
Background: The treatment of symptomatic uncomplicated colonic diverticular disease (SUDD) is still under debate, and new data show a pathogenic role of dysbiosis and low-grade inflammation in intestinal mucosa.
Attilio Giacosa, Antonella Riva, Giovanna Petrangolini, Pietro Allegrini, Teresa Fazia, Luisa Bernardinelli, Clara Gasparri, Milena Anna Faliva, Gabriella Peroni, Simone Perna, Mariangela Rondanelli   +10 more
doaj   +2 more sources

Faecal Calprotectin: A Non-Invasive Marker for Diagnosing and Monitoring Acute Diverticulitis [PDF]

Medical Sciences
Background: Acute diverticulitis (AD) is a prevalent gastrointestinal disorder with a significant recurrence rate. Faecal calprotectin (FC) is a non-invasive biomarker of intestinal inflammation, but its role in diagnosing and monitoring diverticulitis ...
Aamer Mohammed, Yahiya Baig, Alexandra E. Butler   +2 more
doaj   +2 more sources